Breaking News Instant updates and real-time market news.

IFF

International Flavors

$131.66

0.71 (0.54%)

04:55
10/16/18
10/16
04:55
10/16/18
04:55

International Flavors upgraded to Buy from Hold at Deutsche Bank

Deutsche Bank analyst Faiza Alwy upgraded International Flavors & Fragrances to Buy and raised her price target for the shares to $154 from $126. International Flavors is currently trading at a 20% discount, and well below its 10-year average to global specialty ingredients peers, Alwy tells investors in a research note. The analyst also views the company's acquisition of Frutarom as strategically sound and says she's now more comfortable with the integration strategy.

  • 13

    Nov

IFF International Flavors
$131.66

0.71 (0.54%)

06/08/18
ARGS
06/08/18
DOWNGRADE
ARGS
Hold
International Flavors downgraded to Hold from Buy at Argus
Argus analyst John Staszak downgraded International Flavors to Hold from Buy citing the lofty acquisition price of Frutarom, which will not contribute to 2018 earnings and only modestly to 2019 earnings. Further, Staszak is concerned the company will overpay for growth following the announced plans to boost revenue by $500M to $1B in new acquisitions by end of 2020.
05/14/18
05/14/18
DOWNGRADE
Target $120

Underweight
International Flavors downgraded to Underweight from Neutral at JPMorgan
As previously reported, JPMorgan analyst Jeffrey Zekauskas downgraded International Flavors & Fragrances to Underweight from Neutral, estimating that its equity offering to finance the purchase of Frutarom is equivalent to about 18m shares. He assumes the stock would be issued before the end of 2018 and he thinks the shorter-term risk/reward for the stock is more challenging given the magnitude of the possible offering, he tells investors. Zekauskas lowered our 2018-2020 EPS forecasts to account for higher share count assumptions and lowered his price target to $120 from $130.
05/14/18
JPMS
05/14/18
DOWNGRADE
JPMS
Underweight
Correction: International Flavors downgraded to Underweight at JPMorgan
05/10/18
BERN
05/10/18
NO CHANGE
Target $155
BERN
Outperform
International Flavors price target lowered to $155 from $160 at Bernstein
Bernstein analyst Gunther Zechmann lowered his price target for International Flavors to $155 from $160 following its announcement that it will acquire Frutarom in a $7.1B transaction. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

YRD

Yirendai

$15.47

-1.75 (-10.16%)

17:01
11/12/18
11/12
17:01
11/12/18
17:01
Earnings
Yirendai reports Q3 adjusted income per ADS 87c, consensus 52c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LTM

Latam Airlines

$8.96

-0.39 (-4.17%)

17:00
11/12/18
11/12
17:00
11/12/18
17:00
Hot Stocks
Latam Airlines reports October passenger traffic up 1.5% »

LATAM Airlines Group …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ETON

Eton Pharmaceuticals

$0.00

(0.00%)

16:53
11/12/18
11/12
16:53
11/12/18
16:53
Syndicate
Eton Pharmaceuticals 3.6M share IPO priced at $6.00 »

National Securities acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$60.18

-1.235 (-2.01%)

16:49
11/12/18
11/12
16:49
11/12/18
16:49
Hot Stocks
Energizer names Patrick Moore chairman of the board »

Energizer Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ACIU

AC Immune

$8.74

0.01 (0.11%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Initiation
AC Immune initiated  »

AC Immune initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNT

Kornit Digital

$19.15

-0.88 (-4.39%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Earnings
Kornit Digital reports Q3 adjusted EPS 13c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ZGNX

Zogenix

$40.82

0.05 (0.12%)

16:46
11/12/18
11/12
16:46
11/12/18
16:46
Initiation
Zogenix initiated  »

Zogenix initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ADMS

Adamas Pharmaceuticals

$11.45

-0.455 (-3.82%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Adamas Pharmaceuticals initiated  »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 27

    Nov

  • 27

    Nov

AGN

Allergan

$163.82

-1.77 (-1.07%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Allergan initiated  »

Allergan initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SAGE

Sage Therapeutics

$121.50

-9.46 (-7.22%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Sage Therapeutics initiated  »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

  • 19

    Dec

NBIX

Neurocrine

$103.03

-2.18 (-2.07%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Neurocrine initiated  »

Neurocrine initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HLUYY

Lundbeck

$0.00

(0.00%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Lundbeck initiated  »

Lundbeck initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$134.48

-3.3 (-2.40%)

16:43
11/12/18
11/12
16:43
11/12/18
16:43
Initiation
GW Pharmaceuticals initiated  »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

BHVN

Biohaven Pharmaceutical

$36.42

-2.47 (-6.35%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Biohaven Pharmaceutical initiated  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 27

    Nov

ACAD

Acadia

$18.86

-0.01 (-0.05%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Acadia initiated  »

Acadia initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ALKS

Alkermes

$34.70

-2.98 (-7.91%)

16:41
11/12/18
11/12
16:41
11/12/18
16:41
Initiation
Alkermes initiated  »

Alkermes initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 31

    Jan

GATX

GATX

$76.43

-2.54 (-3.22%)

16:37
11/12/18
11/12
16:37
11/12/18
16:37
Hot Stocks
GATX acquires up to 3,100 railcars for $229M »

GATX Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVGS

Navigator Holdings

$12.03

-0.13 (-1.07%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Earnings
Navigator Holdings reports Q3 EPS 1c, consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GRA

W.R. Grace

$63.83

-0.705 (-1.09%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Hot Stocks
W.R. Grace to increase price for silica-based, molecular sieve products by 7% »

W. R. Grace will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:34
11/12/18
11/12
16:34
11/12/18
16:34
Hot Stocks
AXA Equitable reports Q3 annualized premiums up 2% »

Reports Q3 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:33
11/12/18
11/12
16:33
11/12/18
16:33
Hot Stocks
Breaking Hot Stocks news story on AXA Equitable »

AXA Equitable announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:32
11/12/18
11/12
16:32
11/12/18
16:32
Earnings
AXA Equitable reports Q3 adjusted EPS $1.23, consensus 91c »

Reports Q3 revenue $1.08B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

HAL

Halliburton

$34.17

-0.81 (-2.32%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Halliburton names Lance Loeffler as CFO, Chris Weber to leave company »

Halliburton is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELVT

Elevate Credit

$4.11

-0.08 (-1.91%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Elevate Credit appoints David Peterson Chief Credit Officer »

Elevate Credit announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROP

Roper Technologies

$289.16

-7.67 (-2.58%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Roper Technologies raises quarterly dividend 12% to 46.25c per share »

Roper Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.